STOCK TITAN

Vanguard amendment shows 0 HQY shares after internal realignment (HQY)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

HealthEquity Inc: Amendment No. 9 to a Schedule 13G/A was filed by The Vanguard Group reporting beneficial ownership of 0 shares of common stock, representing 0% of the class. The filing notes an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, with certain Vanguard subsidiaries to report ownership separately.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

Who filed the Schedule 13G/A amendment for HQY?

The filing was submitted by The Vanguard Group. The amendment is signed by Ashley Grim, Head of Global Fund Administration, and lists Vanguard's Malvern, PA address and role as the reporting person.

How many HealthEquity (HQY) shares does Vanguard report owning?

The Vanguard Group reports owning 0 shares (0%) of HealthEquity common stock. The filing's Item 4 explicitly lists Amount beneficially owned: 0 and Percent of class: 0%.

Why does the filing mention an internal realignment at Vanguard?

Vanguard underwent an internal realignment on January 12, 2026 and, under SEC Release No. 34-39538, certain subsidiaries will report beneficial ownership separately from The Vanguard Group.

Does Vanguard state any other person holds more than 5% of HQY here?

No other person's interest exceeds 5% in the securities reported. The filing states that no one else's interest in the reported securities is more than 5%.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026